Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Cynthia Koons Healthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.

Trump Says Talks Are Iran’s ‘Last Chance’ After Threats
42:36

Eight Bosses Share the Biggest Money Regrets in Their Careers
08:43

Bloomberg Businessweek Weekend: July 31st 2026
38:26